Literature DB >> 21671477

Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.

Xueying Sharon Liang1, Ruth M Pfeiffer, William Wheeler, Dennis Maeder, Laurie Burdette, Meredith Yeager, Stephen Chanock, Margaret A Tucker, Alisa M Goldstein, Xiaohong R Yang.   

Abstract

Cutaneous malignant melanoma (CMM) is an etiologically heterogeneous disease with genetic, environmental (sun exposure) and host (pigmentation/nevi) factors and their interactions contributing to risk. Genetic variants in DNA repair genes may be particularly important since their altered function in response to sun exposure-related DNA damage maybe related to risk for CMM. However, systematic evaluations of genetic variants in DNA repair genes are limited, particularly in high-risk families. We comprehensively analyzed DNA repair gene polymorphisms and CMM risk in melanoma-prone families with/without CDKN2A mutations. A total of 586 individuals (183 CMM) from 53 families (23 CDKN2A (+), 30 CDKN2A (-)) were genotyped for 2964 tagSNPs in 131 DNA repair genes. Conditional logistic regression, conditioning on families, was used to estimate trend p-values, odds ratios and 95% confidence intervals for the association between CMM and each SNP separately, adjusted for age and sex. p-Values for SNPs in the same gene were combined to yield gene specific p-values. Two genes, POLN and PRKDC, were significantly associated with melanoma after Bonferroni correction for multiple testing (p = 0.0003 and 0.00035, respectively). DCLRE1B showed suggestive association (p = 0.0006). 28 ∼ 56% of genotyped SNPs in these genes had single SNP p < 0.05. The most significant SNPs in POLN and PRKDC had similar effects in CDKN2A (+) and CDKN2A (-) families. Our finding suggests that polymorphisms in DNA repair genes, POLN and PRKDC, were associated with increased melanoma risk in melanoma families with and without CDKN2A mutations.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671477      PMCID: PMC3274649          DOI: 10.1002/ijc.26231

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.

Authors:  P A van der Velden; L A Sandkuijl; W Bergman; S Pavel; L van Mourik; R R Frants; N A Gruis
Journal:  Am J Hum Genet       Date:  2001-08-07       Impact factor: 11.025

2.  Rank truncated product of P-values, with application to genomewide association scans.

Authors:  Frank Dudbridge; Bobby P C Koeleman
Journal:  Genet Epidemiol       Date:  2003-12       Impact factor: 2.135

3.  Evidence for hSNM1B/Apollo functioning in the HSP70 mediated DNA damage response.

Authors:  Marco Anders; Jens Mattow; Martin Digweed; Ilja Demuth
Journal:  Cell Cycle       Date:  2009-06-01       Impact factor: 4.534

4.  Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.

Authors:  Alisa M Goldstein; Maria Teresa Landi; Shirley Tsang; Mary C Fraser; David J Munroe; Margaret A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-09       Impact factor: 4.254

Review 5.  Human DNA repair genes, 2005.

Authors:  Richard D Wood; Michael Mitchell; Tomas Lindahl
Journal:  Mutat Res       Date:  2005-09-04       Impact factor: 2.433

6.  Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Authors:  A M Goldstein; J P Struewing; A Chidambaram; M C Fraser; M A Tucker
Journal:  J Natl Cancer Inst       Date:  2000-06-21       Impact factor: 13.506

Review 7.  Solar ultraviolet radiation and skin cancer.

Authors:  Charlotte Young
Journal:  Occup Med (Lond)       Date:  2009-03       Impact factor: 1.611

8.  Familial melanoma, pancreatic cancer and germline CDKN2A mutations.

Authors:  Alisa M Goldstein
Journal:  Hum Mutat       Date:  2004-06       Impact factor: 4.878

Review 9.  Melanoma etiology: where are we?

Authors:  Margaret A Tucker; Alisa M Goldstein
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

10.  Processing of clustered DNA damage in human breast cancer cells MCF-7 with partial DNA-PKcs deficiency.

Authors:  Prakash Peddi; Dave C Francisco; Angela M Cecil; Jessica M Hair; Mihalis I Panayiotidis; Alexandros G Georgakilas
Journal:  Cancer Lett       Date:  2008-06-11       Impact factor: 8.679

View more
  8 in total

1.  Exonuclease 1 (EXO1) gene variation and melanoma risk.

Authors:  Fengju Song; Abrar A Qureshi; Jiangwen Zhang; Jiangwen Zhan; Christopher I Amos; Jeffrey E Lee; Qingyi Wei; Jiali Han
Journal:  DNA Repair (Amst)       Date:  2012-01-09

2.  Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.

Authors:  Thomas P Potjer; Nienke van der Stoep; Jeanine J Houwing-Duistermaat; Ingrid C A W Konings; Cora M Aalfs; Peter C van den Akker; Margreet G Ausems; Charlotte J Dommering; Lizet E van der Kolk; Merel C Maiburg; Liesbeth Spruijt; Anja Wagner; Hans F A Vasen; Frederik J Hes
Journal:  BMC Res Notes       Date:  2015-06-26

3.  Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers.

Authors:  E Christodoulou; M Visser; T P Potjer; N van der Stoep; M Rodríguez-Girondo; R van Doorn; N Gruis
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

Review 4.  Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.

Authors:  Zizhen Ming; Su Yin Lim; Helen Rizos
Journal:  Biomolecules       Date:  2020-10-15

5.  On the interplay of telomeres, nevi and the risk of melanoma.

Authors:  Clara Bodelon; Ruth M Pfeiffer; Valentina Bollati; Julien Debbache; Donato Calista; Paola Ghiorzo; Maria Concetta Fargnoli; Giovanna Bianchi-Scarra; Ketty Peris; Mirjam Hoxha; Amy Hutchinson; Laurie Burdette; Laura Burke; Shenying Fang; Margaret A Tucker; Alisa M Goldstein; Jeffrey E Lee; Qingyi Wei; Sharon A Savage; Xiaohong R Yang; Christopher Amos; Maria Teresa Landi
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

6.  Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.

Authors:  Xueying Liang; Ruth M Pfeiffer; Wen-Qing Li; Myriam Brossard; Laura S Burke; William Wheeler; Donato Calista; Maria Concetta Fargnoli; Paola Ghiorzo; Ketty Peris; Giovanna Bianchi-Scarra; Valerie Chaudru; Diana Zelenika; Dennis Maeder; Laurie Burdette; Meredith Yeager; Stephen Chanock; Maria Teresa Landi; Florence Demenais; Margaret A Tucker; Alisa M Goldstein; Xiaohong R Yang
Journal:  J Invest Dermatol       Date:  2013-07-26       Impact factor: 8.551

Review 7.  SNM1B/Apollo in the DNA damage response and telomere maintenance.

Authors:  Maren Schmiester; Ilja Demuth
Journal:  Oncotarget       Date:  2017-07-18

8.  Different genetic mechanisms mediate spontaneous versus UVR-induced malignant melanoma.

Authors:  Blake Ferguson; Herlina Y Handoko; Pamela Mukhopadhyay; Arash Chitsazan; Lois Balmer; Grant Morahan; Graeme J Walker
Journal:  Elife       Date:  2019-01-25       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.